Cepharanthine
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Cepharanthine
- DrugBank Accession Number
- DB16824
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 606.719
Monoisotopic: 606.272986952 - Chemical Formula
- C37H38N2O6
- Synonyms
- Cepharanthin
- Cepharanthine
- External IDs
- BRN 0075231
- CCRIS 6539
- NSC-623442
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Alkaloids
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antineoplastic Agents
- Antineoplastic Agents, Phytogenic
- Antirheumatic Agents
- Compounds used in a research, industrial, or household setting
- Dioxoles
- Heterocyclic Compounds, Fused-Ring
- Isoquinolines
- Peripheral Nervous System Agents
- Protective Agents
- Radiation-Protective Agents
- Sensory System Agents
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7592YJ0J6T
- CAS number
- 481-49-2
- InChI Key
- YVPXVXANRNDGTA-WDYNHAJCSA-N
- InChI
- InChI=1S/C37H38N2O6/c1-38-13-11-24-18-31(41-4)33-20-27(24)28(38)16-23-7-10-30(40-3)32(17-23)44-26-8-5-22(6-9-26)15-29-35-25(12-14-39(29)2)19-34-36(37(35)45-33)43-21-42-34/h5-10,17-20,28-29H,11-16,21H2,1-4H3/t28-,29+/m1/s1
- IUPAC Name
- (14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2^{16,19}.1^{3,10}.1^{21,25}.0^{4,8}.0^{31,35}.0^{14,39}]nonatriaconta-1(34),3,8,10(39),16,18,21,23,25(36),31(35),32,37-dodecaene
- SMILES
- [H][C@@]12CC3=CC(OC4=CC=C(C[C@]5([H])N(C)CCC6=C5C(OC5=CC1=C(CCN2C)C=C5OC)=C1OCOC1=C6)C=C4)=C(OC)C=C3
References
- General References
- Not Available
- External Links
- KEGG Compound
- C09391
- ChemSpider
- 9791
- BindingDB
- 50423643
- ChEBI
- 3546
- ChEMBL
- CHEMBL449782
- ZINC
- ZINC000030726863
- Wikipedia
- Cepharanthine
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 2 Completed Treatment Asymptomatic COVID-19 / Coronavirus Disease 2019 (COVID‑19) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00483 mg/mL ALOGPS logP 5.31 ALOGPS logP 6.42 Chemaxon logS -5.1 ALOGPS pKa (Strongest Basic) 8.14 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 61.86 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 172.96 m3·mol-1 Chemaxon Polarizability 66 Å3 Chemaxon Number of Rings 8 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 241.6101625 predictedDarkChem Lite v0.1.0 [M-H]- 249.8468625 predictedDarkChem Lite v0.1.0 [M-H]- 240.7559 predictedDeepCCS 1.0 (2019) [M+H]+ 241.2861625 predictedDarkChem Lite v0.1.0 [M+H]+ 250.5386625 predictedDarkChem Lite v0.1.0 [M+H]+ 242.58078 predictedDeepCCS 1.0 (2019) [M+Na]+ 241.3841625 predictedDarkChem Lite v0.1.0 [M+Na]+ 250.4993625 predictedDarkChem Lite v0.1.0 [M+Na]+ 248.1866 predictedDeepCCS 1.0 (2019)
Drug created at July 15, 2022 15:59 / Updated at December 01, 2022 11:30